hero banner

News Releases

Strong foundations laid ahead of planned regulatory submissions in 2023 LONDON, U.K. AND DALLAS, TX, U.S.  – Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company with proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound care,
Feb 27, 2023
Data from the study to support regulatory submissions on track for 2023 Participation from distinguished EU principal investigators provides significant endorsement for DeepView™    LONDON, U.K. AND DALLAS, TX, U.S  -Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company with
Feb 21, 2023
LONDON, U.K. AND DALLAS, TX, U.S.  – Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company with proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound care, announces that, as at the date of this announcement, there are 136,201,515
Feb 03, 2023
Unaudited cash, revenue and loss for the year expected to be ahead of expectations LONDON, U.K AND DALLAS, TX, U.S.  – Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company that develops proprietary AI algorithms and optical technology for faster and more accurate treatment
Jan 16, 2023
Accomplished technology executive and innovator Dr. Niko Pagoulatos joins Spectral MD LONDON, U.K AND DALLAS, TX, U.S.  – Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company with proprietary AI algorithms and optical technology for rapid and accurate treatment decisions in wound
Nov 09, 2022
LONDON, U.K AND DALLAS, TX, U.S.  Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company with proprietary AI and optical technology for faster and more accurate treatment decisions in wound care, announces that a block listing application (“Block Listing”) has been made to the London
Nov 07, 2022
Spectral MD expected to exceed full year market expectations for revenue, margins, and EBITDA Burn and Diabetic Foot Ulcer (“DFU”) clinical studies remain on track LONDON, U.K AND DALLAS, TX, U.S.  Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company with proprietary AI algorithms
Nov 02, 2022
LONDON, U.K AND DALLAS, TX, U.S.  Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company with proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound care, announces that Erich Spangenberg, Non-Executive Director, has elected to
Oct 24, 2022
LONDON, U.K AND DALLAS, TX, U.S.  Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company with proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound care, announces the exercise of options by certain employees of the Company (the
Oct 12, 2022